453
The plasma concentrations of both drugs were significantly increased during the coadministration, and the cetirizine concentration decreased on cessation of pilsicainide despite the fact that treatment with cetirizine was continued, which suggested that the fainting was induced by the pharmacokinetic drug interaction.
 fainting: Effect; pilsicainide: Treatment; cetirizine: Treatment; pilsicainide: Treatment.Drug; cetirizine: Treatment.Drug; pilsicainide: Combination.Drug; cetirizine: Combination.Drug
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: adverse event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Subject.Disorder, Treatment.Route, Subject.Race, Treatment.Time_elapsed, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 fainting: Effect; pilsicainide: Treatment; cetirizine: Treatment; pilsicainide: Treatment.Drug; cetirizine: Treatment.Drug; pilsicainide: Combination.Drug; cetirizine: Combination.Drug